Ionis Pharmaceuticals

Filed a patent for "compounds and methods for reducing atn1 expression" on Wed, August 23, 2023

Filed a patent for "compounds and methods for reducing tubb4a expression" on Tue, August 1, 2023

Filed a patent for "cd29 targeted oligonucleotides and uses thereof" on Fri, June 30, 2023

Filed a patent for "devices and methods for storage of aqueous solutions of modified oligonucleotide compounds" on Thu, February 9, 2023

Filed a patent for "compounds and methods for modulating alpha-synuclein expression" on Fri, February 17, 2023

Filed a patent for "sugar modified oligonucleotides and uses thereof" on Wed, May 3, 2023

Filed a patent for "compounds and methods for modulating alpha-synuclein expression" on Tue, October 3, 2023

Filed a patent for "compounds and methods for reducing pln expression" on Wed, April 5, 2023

Filed a patent for "compounds and methods for reducing pln expression" on Thu, June 15, 2023

Filed a patent for "compounds and methods for reducing pln expression" on Tue, March 5, 2024

Filed a patent for "compounds and methods for reducing pln expression" on Thu, December 5, 2024

Filed a patent for "compositions and methods for modulating apolipoprotein (a) expression" on Thu, October 24, 2024

Filed a patent for "allele-selective compounds and methods for modulating huntingtin expression" on Fri, February 17, 2023

Filed a patent for "allele-selective compounds and methods for modulating huntingtin expression" on Tue, October 3, 2023

Filed a patent for "allele-selective compounds and methods for modulating huntingtin expression" on Thu, October 3, 2024

Filed a patent for "compounds and methods for reducing app expression" on Fri, February 17, 2023

Filed a patent for "glp-1 receptor ligand moiety conjugated oligonucleotides and uses thereof" on Thu, September 5, 2024

Filed a patent for "compositions and methods for modulation of smn2 splicing in a subject" on Tue, December 20, 2022

Filed a patent for "modulating apolipoprotein (a) expression" on Fri, September 23, 2022

Filed a patent for "modulating apolipoprotein (a) expression" on Thu, July 4, 2024

Filed a patent for "oligomeric compounds for reducing dmpk expression" on Thu, April 13, 2023

Filed a patent for "compounds and methods for reducing mecp2 expression" on Fri, September 23, 2022

Filed a patent for "compounds and methods for reducing mecp2 expression" on Fri, September 23, 2022

Filed a patent for "compositions and methods for modulating ttr expression" on Thu, May 18, 2023

Filed a patent for "compounds and methods for reducing psd3 expression" on Thu, June 1, 2023